You can buy or sell Evolus and other stocks, options, ETFs, and crypto commission-free!
Evolus, Inc. Common Stock, also called Evolus, is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. Read More It offers products under the brand of Jeuveau. The company was founded in November, 2012 and is headquartered in Newport Beach, CA.
Newport Beach, California
52 Week High
52 Week Low
Seeking AlphaMay 16
Evolus down 10% premarket on 4M-share stock sale
Evolus (NASDAQ:EOLS) slumps 10% premarket on light volume in reaction to the sale of 4M common shares by ALPHAEON. Underwriter Morgan Stanley will have the option to buy up to 600K additional shares.
Seeking AlphaMay 15
Evolus And The U.S. Cosmetic Neurotoxin Landscape
EOLS is in the midst of launching their Botox alternative in North America and will be competing with Botox, Xeomin and Dysport. Evolus (EOLS) is a one drug company that is gearing up to enter the personal aesthetics arena. They look to compete against the market leader, Allergan (AGN), with their own version of Botox, which will be branded as Jeuveau in the US. They have also recently received a positive opinion from the CHMP in the EU for their product and are awaiting the final decision, which should co...
Expected Aug 1, After Hours